CBIO
Crescent Biopharma
CBIO
CBIO
50 hedge funds and large institutions have $135M invested in Crescent Biopharma in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
61% more capital invested
Capital invested by funds: $83.5M → $135M (+$51.1M)
Holders
50
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$17.8M | |
| 2 | +$2.77M | |
| 3 | +$2.76M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.15M |
Top Sellers
| 1 | -$363K | |
| 2 | -$86.2K | |
| 3 | -$78.4K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$12.4K |
| 5 |
Morgan Stanley
New York
|
-$10.8K |